Remote Monitoring for Diabetic Foot Ulcers
Trial Summary
What is the purpose of this trial?
This research is being done to compare two different methods of wound monitoring for chronic wounds: remote wound monitoring using a smartphone app and in-person wound monitoring in a clinic setting. This will be a pilot non-blinded randomized controlled feasibility trial. The investigators will enroll 120 patients with an active diabetic foot ulcer (DFU) who present to the multidisciplinary diabetic foot clinic in Baltimore, Maryland. Patients will be computer randomized 1:1 to receive wound care monitoring using remote DFU monitoring technology or standard in-person monitoring for 12 weeks.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Remote wound monitoring technology for diabetic foot ulcers?
Research shows that remote monitoring using smartphone apps can improve wound care by enhancing communication between patients and providers, and by allowing timely identification and management of wound issues. This approach has been effective in managing postsurgical wounds and is anticipated to improve care for diabetic foot ulcers by empowering patients in self-care and providing timely monitoring of risk factors.12345
Is remote monitoring technology for wound care safe for humans?
How does the remote wound monitoring technology treatment for diabetic foot ulcers differ from other treatments?
Remote wound monitoring technology is unique because it uses smartphone apps and digital health tools to monitor and manage diabetic foot ulcers from a distance, allowing for timely intervention and reducing the need for frequent clinic visits. This approach empowers patients in self-care and provides continuous monitoring, which can help prevent complications and improve outcomes compared to traditional in-person treatments.23589
Research Team
Caitlin Hicks, MD
Principal Investigator
Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for adults over 18 with diabetic foot ulcers who are receiving treatment, can use a smartphone, and speak English. It's not suitable for those without help to scan wounds in hard-to-reach areas, have infrequent dressing changes, or have wounds too large for a single app scan.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either remote wound monitoring using a smartphone app or standard in-person monitoring for diabetic foot ulcers
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Remote wound monitoring technology
Remote wound monitoring technology is already approved in United States for the following indications:
- Diabetic foot ulcers
- Chronic wound management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator